Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

Vera Therapeutics, Inc.

VERA · Nasdaq · CIK 0001831828 · Healthcare · Biotechnology

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

25 Form 4 transaction lines observed in the same window
18 sales · 7 option, withholding, award, gift or other lines

Last qualifying purchase2025-12-11 · ENRIGHT PATRICK G · $250.0K

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesHigh
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Fordyce MarshallPRESIDENT AND CEO
○▼▼○▼▼○▼▼○▼○▼
Young Joseph RSVP, FINANCE, CHIEF ACCT OFFCR
○
Boman Nancy LeeChief Regulatory Officer
○
● Purchase▼ Sale○ Other

—

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2025-12-11 · ENRIGHT PATRICK G.

Recent Form 4 activity

1Purchases
33Sales
20Other Form 4 lines
33SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING18 sale line(s) · context only
OTHER7 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
17,240,397
Previous report
17,035,040
Avg daily volume
2,212,016
Days to cover
7.8

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2025-12-11ENRIGHT PATRICK GPurchase (P)Class A Common Stock5,882USD 42.50USD 249,985SEC filing ↗
2025-06-24ENRIGHT PATRICK GPurchase (P)Class A Common Stock40,607USD 22.35USD 907,566SEC filing ↗
2025-06-23ENRIGHT PATRICK GPurchase (P)Class A Common Stock209,393USD 20.87USD 4,370,032SEC filing ↗
2024-01-30Katabi MahaPurchase (P)Class A Common Stock161,290USD 31.00USD 4,999,990SEC filing ↗
2023-06-23Grant SeanPurchase (P)Class A Common Stock5,000USD 16.60USD 83,000SEC filing ↗
2023-06-20COMMODORE CAPITAL LPPurchase (P)Class A Common Stock448,217USD 15.17USD 6,799,452SEC filing ↗
2023-03-30SEIDENBERG BETH CPurchase (P)Class A Common Stock2,300USD 7.24USD 16,652SEC filing ↗
2023-03-28SEIDENBERG BETH CPurchase (P)Class A Common Stock23,908USD 7.24USD 173,094SEC filing ↗
2023-03-27SEIDENBERG BETH CPurchase (P)Class A Common Stock1,633USD 7.24USD 11,823SEC filing ↗
2023-03-24SEIDENBERG BETH CPurchase (P)Class A Common Stock1,833USD 7.24USD 13,271SEC filing ↗
2023-03-20SEIDENBERG BETH CPurchase (P)Class A Common Stock15,252USD 7.21USD 109,967SEC filing ↗
2023-03-17SEIDENBERG BETH CPurchase (P)Class A Common Stock74,045USD 7.12USD 527,200SEC filing ↗
2023-03-16SEIDENBERG BETH CPurchase (P)Class A Common Stock60,097USD 7.09USD 426,088SEC filing ↗
2023-03-15SEIDENBERG BETH CPurchase (P)Class A Common Stock32,844USD 7.12USD 233,849SEC filing ↗
2023-03-10SEIDENBERG BETH CPurchase (P)Class A Common Stock48,003USD 7.16USD 343,701SEC filing ↗

Form 4 evidence

54 transaction lines in the latest 365-day window; 388 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-15Fordyce MarshallSale (S)Class A Common Stock18,500USD 37.00USD 684,500SEC filing ↗
2026-09-15Fordyce MarshallOption exercise / conversion (M)Class A Common Stock18,500USD 2.90USD 53,650SEC filing ↗
2026-09-11Young Joseph ROption exercise / conversion (M)Class A Common Stock5,000USD 3.94USD 19,700SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-15Fordyce MarshallSale (S)Class A Common Stock18,500USD 37.00USD 684,500SEC filing ↗
2026-09-15Fordyce MarshallOption exercise / conversion (M)Class A Common Stock18,500USD 2.90USD 53,650SEC filing ↗
2026-09-11Young Joseph ROption exercise / conversion (M)Class A Common Stock5,000USD 3.94USD 19,700SEC filing ↗
2026-09-02Fordyce MarshallSale (S)Class A Common Stock18,500USD 35.12USD 649,720SEC filing ↗
2026-09-02Fordyce MarshallOption exercise / conversion (M)Class A Common Stock18,500USD 2.90USD 53,650SEC filing ↗
2026-08-03Boman Nancy LeeAward / grant (A)Class A Common Stock44,987USD 0.00USD 0SEC filing ↗
2026-07-07Fordyce MarshallSale (S)Class A Common Stock46,250USD 42.29USD 1,956,086SEC filing ↗
2026-07-07Fordyce MarshallOption exercise / conversion (M)Class A Common Stock46,250USD 2.90USD 134,125SEC filing ↗
2026-07-07Fordyce MarshallSale (S)Class A Common Stock46,250USD 42.29USD 1,956,086SEC filing ↗
2026-06-23Fordyce MarshallSale (S)Class A Common Stock18,500USD 37.93USD 701,749SEC filing ↗
2026-06-23Fordyce MarshallOption exercise / conversion (M)Class A Common Stock18,500USD 2.90USD 53,650SEC filing ↗
2026-06-23Fordyce MarshallSale (S)Class A Common Stock18,500USD 37.93USD 701,749SEC filing ↗
2026-05-12Fordyce MarshallSale (S)Class A Common Stock18,500USD 36.74USD 679,766SEC filing ↗
2026-05-12Fordyce MarshallOption exercise / conversion (M)Class A Common Stock18,500USD 2.90USD 53,650SEC filing ↗
2026-05-12Fordyce MarshallSale (S)Class A Common Stock18,500USD 36.74USD 679,766SEC filing ↗
2026-04-14Fordyce MarshallSale (S)Class A Common Stock22,951USD 44.05USD 1,010,993SEC filing ↗
2026-03-23Wright-Mitchell JaneAward / grant (A)Class A Common Stock42,403USD 0.00USD 0SEC filing ↗
2026-03-13Young Joseph ROption exercise / conversion (M)Class A Common Stock10,000USD 3.94USD 39,400SEC filing ↗
2026-02-23Young Joseph RSale (S)Class A Common Stock3,117USD 41.98USD 130,852SEC filing ↗
2026-02-23Turner William D.Sale (S)Class A Common Stock2,187USD 41.98USD 91,810SEC filing ↗
2026-02-23Skelton Laurence MatthewSale (S)Class A Common Stock1,582USD 41.98USD 66,412SEC filing ↗
2026-02-23JOHNSON DAVID LEESale (S)Class A Common Stock2,579USD 41.98USD 108,266SEC filing ↗
2026-02-23Grant SeanSale (S)Class A Common Stock4,949USD 41.98USD 207,759SEC filing ↗
2026-02-23Fordyce MarshallSale (S)Class A Common Stock16,925USD 41.98USD 710,512SEC filing ↗
2026-02-23Brenner RobertSale (S)Class A Common Stock2,151USD 41.98USD 90,299SEC filing ↗
2026-02-04Young Joseph RAward / grant (A)Class A Common Stock10,000USD 0.00USD 0SEC filing ↗
2026-02-04Turner William D.Award / grant (A)Class A Common Stock25,000USD 0.00USD 0SEC filing ↗
2026-02-04Skelton Laurence MatthewAward / grant (A)Class A Common Stock20,000USD 0.00USD 0SEC filing ↗
2026-02-04JOHNSON DAVID LEEAward / grant (A)Class A Common Stock20,000USD 0.00USD 0SEC filing ↗
2026-02-04Grant SeanAward / grant (A)Class A Common Stock25,000USD 0.00USD 0SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerVERA
CIK0001831828
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNasdaq

Data coverage

Local Form 4 history388 transaction lines from 2021-05-17 to 2026-09-15
48 P purchase lines · 188 S sale lines · 152 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.